← Back to Search

Soft exosuit for Stroke

N/A
Waitlist Available
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up last 30 seconds of maximal effort exercise test.
Awards & highlights

Study Summary

High intensity exercise is known to improve a person's ability to learn new motor skills. The goal of this project is to evaluate if a robotic exosuit can help people who have had a stroke perform walking rehabilitation at higher intensities than they are able to without the exosuit. The investigators will measure exercise training intensity, biomarkers of neuroplasticity (e.g., brain-derived neurotrophic factor; BDNF), and motor learning when people poststroke exercise with and without the exosuit. For this protocol, exosuits developed in collaboration with ReWalk™ Robotics will be used. Aim 1: Determine the effects of a soft robotic exosuit on gait training intensity and serum BDNF in persons post-stroke completing a single bout of high intensity walking. Hypothesis 1: Exosuits will allow individuals post-stroke to (i) walk at higher intensities or (ii) walk at a high intensity for longer durations. Hypothesis 2: Training at a higher intensity, or training at high intensity for longer durations, will result in increased serum BDNF. Aim 2: Determine the effects of a soft robotic exosuit on gait biomechanics measured after a single bout of high intensity walking with versus without a soft robotic exosuit. Hypothesis 3: A single bout of high intensity walking with an exosuit will lead to demonstrably better gait biomechanics than a single bout of high intensity exercise without an exosuit.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Concentration of brain-derived neurotrophic factor (BDNF)
Duration of high intensity exercise
Forward Propulsion
+1 more
Other outcome measures
International Physical Activities Questionnaire
Number of Participants with Rs6265

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise testing with soft exosuit assistanceExperimental Treatment1 Intervention
Progressive cardiovascular exercise testing on a treadmill with soft exosuit assistance.
Group II: Exercise testing without soft exosuit assistanceActive Control1 Intervention
Progressive cardiovascular exercise testing on a treadmill.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Soft exosuit
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
114 Previous Clinical Trials
12,279 Total Patients Enrolled
2 Trials studying Stroke
69 Patients Enrolled for Stroke
American Heart AssociationOTHER
326 Previous Clinical Trials
4,933,615 Total Patients Enrolled
39 Trials studying Stroke
3,925,062 Patients Enrolled for Stroke
Harvard UniversityOTHER
229 Previous Clinical Trials
474,494 Total Patients Enrolled
3 Trials studying Stroke
83 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025